These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1652038)

  • 1. [Inhibition by proton irradiation on the development of invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice].
    Ohtani M; Noguchi R; Miyanaga N; Koiso K; Tsuji H; Arimoto T; Inada T; Kitagawa Y; Tsujii H; Tanaka Y
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):821-5. PubMed ID: 1652038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M; Kakizoe T; Nishio Y; Sato S; Sugimura T; Fukushima S; Niijima T
    Cancer Res; 1986 Apr; 46(4 Pt 2):2001-4. PubMed ID: 3948177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain differences in mice with invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M; Kakizoe T; Sato S; Sugimura T; Fukushima S
    J Cancer Res Clin Oncol; 1986; 112(2):107-10. PubMed ID: 3771618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha-difluromethylornithine on the development of deeply invasive urinary bladder carcinomas in mice.
    Samma S; Uchida K; Seidenfeld J; Oyasu R
    Urol Res; 1990; 18(4):277-80. PubMed ID: 2219591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC; Murphy WM; Daniel DS
    J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide.
    Numoto S; Yoshida M; Otsuka H
    Gan; 1981 Oct; 72(5):647-54. PubMed ID: 7327366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okajima E; Denda A; Ozono S; Takahama M; Akai H; Sasaki Y; Kitayama W; Wakabayashi K; Konishi Y
    Cancer Res; 1998 Jul; 58(14):3028-31. PubMed ID: 9679967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of high-grade, high-stage carcinomas in the rat urinary bladder.
    Oyasu R; Samma S; Ozono S; Bauer K; Wallemark CB; Homma Y
    Cancer; 1987 Feb; 59(3):451-8. PubMed ID: 3791155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)].
    Miyakawa M; Yoshida O
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):258-62. PubMed ID: 6820893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Promotive effects of intravesical instillation of dimethylsulfoxide on bladder carcinogenesis in mice].
    Ohtani M; Miyanaga N; Noguchi R; Sasaki A; Akaza H; Koiso K; Tanaka Y; Tobisu K; Kakizoe T
    Nihon Hinyokika Gakkai Zasshi; 1992 Sep; 83(9):1423-8. PubMed ID: 1434283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal models of bladder cancer].
    Fukushima S
    Hinyokika Kiyo; 1988 Nov; 34(11):1923-7. PubMed ID: 3242366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low susceptibility of nude mice to induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine.
    Tamano S; Shirai T; Kawabe M; Ni-I H; Mori Y; Okada M; Fukushima S
    Toxicol Pathol; 1992; 20(2):205-11. PubMed ID: 1475581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in B6D2F1 mice.
    Ogawa K; Uzvolgyi E; St John MK; de Oliveira ML; Arnold L; Cohen SM
    Mol Carcinog; 1998 Jan; 21(1):70-9. PubMed ID: 9473773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
    Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Elkin M; Ayesh S; Schneider T; de Groot N; Hochberg A; Ariel I
    Carcinogenesis; 1998 Dec; 19(12):2095-9. PubMed ID: 9886562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
    Dahm HH; von der Haar C; Rübben H
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1253-60. PubMed ID: 27033373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
    Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of antitumor effects of thymosin on rat and mouse urinary bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Wada S; Kinoshita Y; Kamizuru M; Asai Y; Iwata H; Ikemoto S; Hato F; Kishimoto T; Fukushima S
    Oncol Res; 1996; 8(3):139-44. PubMed ID: 8823810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.